SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-021783
Filing Date
2023-06-20
Accepted
2023-06-20 08:58:04
Documents
13
Period of Report
2023-06-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52953
2 ex2-1.htm EX-2.1 360582
  Complete submission text file 0001493152-23-021783.txt   658074

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE xtnt-20230618.xsd EX-101.SCH 2971
4 XBRL LABEL FILE xtnt-20230618_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE xtnt-20230618_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3544
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 231023594
SIC: 2836 Biological Products, (No Diagnostic Substances)